Pretraga
Rezultati
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY) [2025]
Colombel, Jean Frederic; ...; Sreckovic, Slobodan; ...; (broj, koautora 33)Assessment of body composition parameters in patients with inflammatory bowel disease treated with biological therapy
[2024]
Spirić, Jelena; Topličanin, Aleksandar; Vuksanović, S.; Nikolić, Andreja; Jovičić, Ivana A.; Đuranović, Srđan P. 








A unique clinical phenotype of primary sclerosing cholangitis associated with Crohns disease [2012]
Halliday, J. S.; Đorđević, Jelena D.; Lust, M.; Culver, E. L.; Braden, B.; Travis, S. P. L.; Chapman, R. W. G.Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents [2015]
Karmiris, Konstantinos; ...; Tarabar, Dino K; ...; (broj, koautora 20)The effect of antiTNF alpha and anti-integrin agents on liver steatosis in inlamatory bowel disease patients with non-alcoholic fatty liver disease [2023]
Mitrovic, M; Markovic, Srdjan T; Kalaba, Ana; Zaric, Dusan; Kralj, D; Milic, A; Svorcan, Petar VLong term efficacy and safety for Sequential Rescue Treatments in patents with steroid refractory Ulcerative Colitis - Two years follow up data [2015]
Protic, Marijana B; Frei, Pascal; Manser, C; Knezevic, Tamara; Mottet, Christian; Juillerat, Pascal; Markovic, S; Beglinger, Christoph; Jojic, Njegica Z; Vavricka, Stephan;
Rogler, Gerhard; Seibold, Frank;
Prevalence of anemia in Serbian patients with inflammatory bowel disease [2014]
Mijac, Dragana D



Fecal calprotectin as suitable biomarker in evaluation of histological disease activity [2017]
Knezevic-Ivanovski, Tamara; Knezevic-Usaj, Slavica F; Gligorijevic, Vladimir; Markovic, Srdjan T; Svorcan, Petar V; Nedeljkovic-Protic, Marijana BP094 Strain dependent difference in the progression of dextran sulphate sodium induced colitis is a consequence of the cross-talk between colon-infiltrating dendritic cells and T regulatory cells
[2018]
B Simovic Markovic 

















Long-term safety and efficacy of the anti-MAdCAM monoclonal antibody SHP647 for the treatment of Crohn's disease: the OPERA II study [2018]
D'Haens, Geert R; Reinisch, Walter; Lee, SD; Tarabar, Dino K; Louis, E; Klopocka, M; Klaus, J; Schreiber, S; Park, DI; Hebuterne, Xavier;
Cataldi, F; Banerjee, A; Gorelick, K; Sandborn, William J;
Filteri
Po tipu
- 65